Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

2018241 citationsJournal Articlehybrid Open Access

Authors

Paulus Kirchhof · University of Birmingham

Karl Georg Hæusler · Atrial Fibrillation NETwork

Benjamin Blank · Atrial Fibrillation NETwork

Joseph de Bono · University of Birmingham

David J. Callans · Hospital of the University of Pennsylvania

Arif Elvan · Isala

Thomas Fetsch ·

Abstract

Continuous apixaban is safe and effective in patients undergoing atrial fibrillation ablation at risk of stroke with respect to bleeding, stroke, and cognitive function. Further research is needed to reduce ablation-related acute brain lesions.

Topics & Keywords

Atrial Fibrillation Management and Outcomes Cardiac Arrhythmias and Treatments Cardiac electrophysiology and arrhythmias

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Heart Journal

Volume 39, Issue 32, pp. 2942-2955

DOI: 10.1093/eurheartj/ehy176

Field-Weighted Citation Impact: 23.41